全文获取类型
收费全文 | 79458篇 |
免费 | 2687篇 |
国内免费 | 114篇 |
专业分类
耳鼻咽喉 | 1120篇 |
儿科学 | 3595篇 |
妇产科学 | 2329篇 |
基础医学 | 8028篇 |
口腔科学 | 1461篇 |
临床医学 | 10072篇 |
内科学 | 12491篇 |
皮肤病学 | 1028篇 |
神经病学 | 7458篇 |
特种医学 | 3456篇 |
外科学 | 15533篇 |
综合类 | 177篇 |
一般理论 | 51篇 |
预防医学 | 5463篇 |
眼科学 | 1025篇 |
药学 | 4250篇 |
中国医学 | 44篇 |
肿瘤学 | 4678篇 |
出版年
2024年 | 9篇 |
2023年 | 2042篇 |
2022年 | 3622篇 |
2021年 | 3708篇 |
2020年 | 4288篇 |
2019年 | 2917篇 |
2018年 | 2213篇 |
2017年 | 2249篇 |
2016年 | 2276篇 |
2015年 | 2476篇 |
2014年 | 4475篇 |
2013年 | 3820篇 |
2012年 | 3905篇 |
2011年 | 3863篇 |
2010年 | 3158篇 |
2009年 | 3164篇 |
2008年 | 3225篇 |
2007年 | 3503篇 |
2006年 | 3286篇 |
2005年 | 2899篇 |
2004年 | 2552篇 |
2003年 | 2357篇 |
2002年 | 2043篇 |
2001年 | 1923篇 |
2000年 | 1680篇 |
1999年 | 1432篇 |
1998年 | 677篇 |
1997年 | 553篇 |
1996年 | 619篇 |
1995年 | 547篇 |
1994年 | 458篇 |
1993年 | 365篇 |
1992年 | 932篇 |
1991年 | 964篇 |
1990年 | 874篇 |
1989年 | 795篇 |
1988年 | 808篇 |
1987年 | 342篇 |
1986年 | 92篇 |
1985年 | 196篇 |
1984年 | 228篇 |
1983年 | 165篇 |
1982年 | 146篇 |
1981年 | 131篇 |
1980年 | 83篇 |
1979年 | 74篇 |
1978年 | 43篇 |
1977年 | 41篇 |
1976年 | 28篇 |
1975年 | 8篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
《Current problems in cardiology》2022,47(9):100925
The Coronary Slow Flow Phenomenon is a syndrome of normal coronary anatomy and delayed progression of contrast medium through the coronary vessels. This research attempts to analyze and compare the systolic and diastolic function of the left and right ventricle in primary Slow Flow and Normal Coronary Flow.Two groups of primary Slow Coronary Flow (33 people) and Normal Coronary Flow (11 people) were included and the systolic and diastolic function of the ventricles was analyzed and compared between them.In the control group 18% of patients had mild and in the case group 24.2% mild, and 3.1% had moderate left ventricular diastolic dysfunction (P >0.05). The frequency distribution of the left and right ventricular systolic dysfunction was similar in the two groups.There was no statistically significant difference between two groups and in the association of cardiac dysfunction, it may be reasonable to investigate other causes. 相似文献
14.
《American journal of surgery》2023,225(1):198-205
BackgroundLiver resection is commonly performed for hepatic tumors, however preoperative risk stratification remains challenging. We evaluated the performance of contemporary prediction models for short-term mortality after liver resection in patients with and without cirrhosis.MethodsThis retrospective cohort study examined National Surgical Quality Improvement Program data. We included patients who underwent liver resections from 2014 to 2019. VOCAL-Penn, MELD, MELD-Na, ALBI, and Mayo risk scores were evaluated in terms of model discrimination and calibration for 30-day post-operative mortality.ResultsA total 15,198 patients underwent liver resection, of whom 249 (1.6%) experienced 30-day post-operative mortality. The VOCAL-Penn score had the highest discrimination (area under the ROC curve [AUC] 0.74) compared to all other models. The VOCAL-Penn score similarly outperformed other models in patients with (AUC 0.70) and without (AUC 0.74) cirrhosis.ConclusionThe VOCAL-Penn score demonstrated superior predictive performance for 30-day post-operative mortality after liver resection as compared to existing clinical standards. 相似文献
15.
16.
《HPB : the official journal of the International Hepato Pancreato Biliary Association》2022,24(9):1511-1518
BackgroundCholangiocarcinomas (CCA) are rare tumours originating from bile duct. Due to their asymptomatic nature they are usually diagnosed when the disease is advanced. Little data exists with respect to their incidence and treatment outcomes in low and middle income countries.MethodA retrospective analysis of a prospectively maintained database of all patients with perihilar (pCCA) and intrahepatic (iCCA) CCA registered between January 2012 and December 2018 was performed.ResultsA total of 760 patients, 427 (56.2%) diagnosed with pCCA and 333 (43.8%) of iCCA were included. Patients with localised, locally advanced and metastatic disease in pCCA were 45.5%, 25.9%, 8.5% and that in iCCA were 22.1%, 10.1% and 67.7% respectively. Only 141 (43.9%, 57 - iCCA, 84 -pCCA) of the total 321 patients started on some definitive cancer directed therapy could complete the intended treatment. The overall curative resection rate for all patients of iCCA was 14.5% whereas for patients of pCCA it was only 10.5%.ConclusionMore than half of CCA patients are not able to complete their intended treatment, being worse for pCCA as compared to iCCA. Early referral and centralisation of treatment for this complex disease might be the way forward to achieve optimal outcomes. 相似文献
17.
《Neuromuscular disorders : NMD》2022,32(1):25-32
Autoantibodies against 3?hydroxy-3-methylglutaryl-CoA reductase (HMGCR) and the signal recognition particle (SRP) are representative antibodies causing immune-mediated necrotizing myopathies (IMNM), called as anti-HMGCR and anti-SRP myopathies, respectively. Here, we analyzed the differences in routine blood test results between 56 anti-HMGCR and 77 anti-SRP myopathy patients. A higher alanine transaminase (ALT) level and a lower aspartate transaminase (AST)/ALT ratio were observed in anti-HMGCR myopathy patients [ALT, 265.7 ± 213.3 U/L (mean ± standard deviation); AST/ALT ratio, 0.88 ± 0.32] than in anti-SRP-myopathy patients (ALT, 179.3 ± 111.2 U/L, p < 0.05; AST/ALT ratio, 1.28 ± 0.40, p < 0.01). In the active phase, anti-HMGCR myopathy often showed ALT predominance, whereas anti-SRP myopathy often showed AST predominance. In addition, there were differences in erythrocyte sedimentation rate (ESR), total cholesterol (TChol) level, and high-density lipoprotein (HDL) level between anti-HMGCR and anti-SRP myopathies (ESR: HMGCR, 24.4 ± 20.8 mm/1 h; SRP, 35.7 ± 26.7 mm/1 h, p = 0.0334; TChol: HMGCR, 226.7 ± 36.6 mg/dL; SRP, 207.6 ± 40.8 mg/dL, p = 0.0163; HDL: HMGCR, 58.4 ± 13.9 mg/dL; SRP, 46.2 ± 17.3 mg/dL, p < 0.01). Additional studies on the differences in routine blood test results may further reveal the pathomechanisms of IMNM. 相似文献
18.
19.
20.